Your browser doesn't support javascript.
loading
Phase III multicenter trial of doxorubicin plus cyclophosphamide followed by paclitaxel compared with doxorubicin plus paclitaxel followed by weekly paclitaxel as adjuvant therapy for women with high-risk breast cancer.
Loesch, David; Greco, F Anthony; Senzer, Neil N; Burris, Howard A; Hainsworth, John D; Jones, Stephen; Vukelja, Svetislava J; Sandbach, John; Holmes, Frankie; Sedlacek, Scot; Pippen, John; Lindquist, Deborah; McIntyre, Kristi; Blum, Joanne L; Modiano, Manuel R; Boehm, Kristi A; Zhan, Feng; Asmar, Lina; Robert, Nicholas.
Afiliação
  • Loesch D; US Oncology Research, The Woodlands, TX, USA. dloesch@carismpi.com
J Clin Oncol ; 28(18): 2958-65, 2010 Jun 20.
Article em En | MEDLINE | ID: mdl-20479419
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Adenocarcinoma / Protocolos de Quimioterapia Combinada Antineoplásica Tipo de estudo: Clinical_trials / Etiology_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Middle aged Idioma: En Ano de publicação: 2010 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Adenocarcinoma / Protocolos de Quimioterapia Combinada Antineoplásica Tipo de estudo: Clinical_trials / Etiology_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Middle aged Idioma: En Ano de publicação: 2010 Tipo de documento: Article